Skip to content

Clinical trials

Lipid Metabolism Disorders trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Lipid Metabolism Disorders Country / region: United States Clear all

62 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20062
20073
20082
20102
20112
20132
20144
20152
20163
20176
20183
20192
20207
20211
20227
20235
20245
20251
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed42
Recruiting8
Active, not recruiting5
Unknown status2
Not yet recruiting1
Approved for marketing1
Suspended1
Terminated1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
University of Texas Southwestern Medical Center5
Kastle Therapeutics, LLC3
Pfizer3
University of Colorado, Denver3
89bio, Inc.2
Akcea Therapeutics2
BTL Industries Ltd.2
Caliway Biopharmaceuticals Co., Ltd.2
Eli Lilly and Company2
National Heart, Lung, and Blood Institute (NHLBI)2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Lipid Metabolism Disorders62
Metabolic Diseases26
Dyslipidemias23
Hyperlipidemias17
Hypercholesterolemia14
Hypertriglyceridemia12
Genetic Diseases, Inborn11
Metabolism, Inborn Errors9
Hyperlipoproteinemias8
Lipid Metabolism, Inborn Errors8

Trials

Showing 1 to 25 of 62. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.